2008•Unpublished venueRequires access

Bioequivalence of enteric coated tablet of Zhengqing Fengtongning

HE Hai-xia

Open publisher page 0 citations

Abstract

Objective: To explore the pharmacokinetics and bioequivalence of two kinds of enteric coated tablet of Zhengqing Fengtongning.Method: A single dose of 45 mg·kg-1 test or reference preparation was administrated by randomized crossover way in 12 rabbits.The plasma concentrations of drug were determined by HPLC.The pharmacokinetics parameters and relative bioequivalence were calculated with 3p97 program.Result: The concentration curves based on drug-time of both test and control preparations were presented by one-compartment model,tmax were(0.81±0.34),(0.60±0.30) h respectively,Cmax were(11.16±0.58),(11.90±1.44) μg·mL-1 respectively,AUC0→t were(61.58±6.70),(60.56±6.67) μg·h·mL-1 respectively,relative bioavailability was(102.77%±15.63)%.Suggesting no significant diffirence between the main pharmacokinetic parameters of two prepations.Conclusion: The two preparations are bioequivalent.

About this research paper

What this paper is about

Objective: To explore the pharmacokinetics and bioequivalence of two kinds of enteric coated tablet of Zhengqing Fengtongning.Method: A single dose of 45 mg·kg-1 test or reference preparation was administrated by randomized crossover way in 12 rabbits.The plasma concentrations of drug were determined by HPLC.The pharmacokinetics parameters and relative bioequivalence were calculated with 3p97 program.Result: The concentration curves based on drug-time of both test and control preparations were presented by one-compartment model,tmax were(0.81±0.34),(0.60±0.30) h respectively,Cmax were(11.16±0.58),(11.90±1.44) μg·mL-1 respectively,AUC0→t were(61.58±6.70),(60.56±6.67) μg·h·mL-1 respectively,relative bioavailability was(102.77%±15.63)%.Suggesting no significant diffirence between the main pharmacokinetic parameters of two prepations.Conclusion: The two preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the pharmacokinetics and bioequivalence of two kinds of enteric coated tablet of Zhengqing Fengtongning.Method: A single dose of 45 mg·kg-1 test or reference preparation was administrated by randomized crossover way in 12 rabbits.The plasma concentrations of drug were determined by HPLC.The pharmacokinetics parameters and relative bioequivalence were calculated with 3p97 program.Result: The concentration curves based on drug-time of both test and control preparations were presented by one-compartment model,tmax were(0.81±0.34),(0.60±0.30) h respectively,Cmax were(11.16±0.58),(11.90±1.44) μg·mL-1 respectively,AUC0→t were(61.58±6.70),(60.56±6.67) μg·h·mL-1 respectively,relative bioavailability was(102.77%±15.63)%.Suggesting no significant diffirence between the main pharmacokinetic parameters of two prepations.Conclusion: The two preparations are bioequivalent.

Key concepts: Bioequivalence, Pharmacokinetics, Bioavailability, Cmax, Crossover study, Pharmacology, High-performance liquid chromatography, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of enteric coated tablet of Zhengqing Fengtongning — Research Paper | ScholarLens